EcoDrugPlus

Amine Oxidase Copper Containing 1

Ensembl ID : ENSCCRG00000041310
Gene Symbol: AOC1
1 Cross references
229 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSCCRG00000013198
Gene Symbol: AOC2
1 Cross references
410 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSCCRG00000063375
Gene Symbol: AOC2
1 Cross references
410 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSCCRG00000041681
Gene Symbol: APCS
1 Cross references
342 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSCCRG00000044186
Gene Symbol: APPB
1 Cross references
202 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSCCRG00000044049
Gene Symbol: APPB
1 Cross references
201 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSCCRG00000021887
Gene Symbol: APP
1 Cross references
203 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSCCRG00000074404
Gene Symbol: APP
1 Cross references
203 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSCCRG00000013298
Gene Symbol: AR
1 Cross references
210 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSCCRG00000053757
Gene Symbol: AR
1 Cross references
210 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSCCRG00000044435
Gene Symbol: AGTR1
1 Cross references
200 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSCCRG00000014634
Gene Symbol: AGTR1
1 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).